Xellar Biosystems
Xellar Biosystems is a wet artificial intelligence biotechnology company that accelerates drug discovery by combining Organ-on-a-Chip technology, multicellular 3D disease model development, and AI/machine learning. Their platform recreates complex human organ microenvironments with vascularization, biomechanical forces, and paracrine signaling for biologically relevant in vitro models. They integrate high-throughput microfluidic devices with advanced imaging and AI-driven data analysis to provide spatiotemporal profiling of disease states and drug responses. Designed for scalability and lab automation, Xellar Biosystems addresses the complexity and efficiency needs of modern drug discovery and development, positioning itself as a cutting-edge innovator in pharma-scale organ-on-chip technology.
Xellar Biosystems
Xellar Biosystems is a wet artificial intelligence biotechnology company that accelerates drug discovery by combining Organ-on-a-Chip technology, multicellular 3D disease model development, and AI/machine learning. Their platform recreates complex human organ microenvironments with vascularization, biomechanical forces, and paracrine signaling for biologically relevant in vitro models. They integrate high-throughput microfluidic devices with advanced imaging and AI-driven data analysis to provide spatiotemporal profiling of disease states and drug responses. Designed for scalability and lab automation, Xellar Biosystems addresses the complexity and efficiency needs of modern drug discovery and development, positioning itself as a cutting-edge innovator in pharma-scale organ-on-chip technology.